Brief: Cyclacel Pharmaceuticals Reports Q4 And FY 2022 Financial Results And Provides Business Update
March 6 (Reuters) - Cyclacel Pharmaceuticals Inc
CYCC.O :
* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CYCLACEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.60
Source text for Eikon: ID:nGNXbZd8nD
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Green Med Solution
See all newsBrief: Bio Green Med Solution Announces Business Combination Agreement To Acquire Future NRG
Bio Green Med Solution Q1 product revenue hits $0.8 mln, net loss narrows
Brief: Bio Green Med Solution Inc Q1 Net Income USD -197 Thousand
Malaysia's Bio Green Med Solution Q4 net loss narrows
Brief: Bio Green Med Solution Inc Q4 Net Income USD -611 Thousand